Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 456

    1.

    Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer. A cost-effectiveness analysis.

    Ladabaum U, Chopra CL, Huang G, Scheiman JM, Chernew ME, Fendrick AM.

    Ann Intern Med. 2001 Nov 6;135(9):769-81.PMID: 11694102 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Cost-effectiveness of colonoscopy in screening for colorectal cancer.

    Sonnenberg A, Delcò F, Inadomi JM.

    Ann Intern Med. 2000 Oct 17;133(8):573-84.PMID: 11033584 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Cost-effectiveness of screening for colorectal cancer in the general population.

    Frazier AL, Colditz GA, Fuchs CS, Kuntz KM.

    JAMA. 2000 Oct 18;284(15):1954-61.PMID: 11035892 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Summaries for patients. Is aspirin a cost-effective addition to colorectal cancer screening?

    [No authors listed]

    Ann Intern Med. 2001 Nov 6;135(9):1. No abstract available. PMID: 11759636 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Chemoprevention of colorectal cancer by aspirin: a cost-effectiveness analysis.

    Suleiman S, Rex DK, Sonnenberg A.

    Gastroenterology. 2002 Jan;122(1):78-84.PMID: 11781283 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening.

    Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG, Habbema JD, Kuipers EJ.

    J Natl Cancer Inst. 2009 Oct 21;101(20):1412-22. Epub 2009 Sep 24.PMID: 19779203 [PubMed - indexed for MEDLINE]Related articles

    7.

    Cost-effectiveness of colorectal cancer screening: comparison of community-based flexible sigmoidoscopy with fecal occult blood testing and colonoscopy.

    O'Leary BA, Olynyk JK, Neville AM, Platell CF.

    J Gastroenterol Hepatol. 2004 Jan;19(1):38-47.PMID: 14675241 [PubMed - indexed for MEDLINE]Related articles

    8.

    Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.

    Tsoi KK, Ng SS, Leung MC, Sung JJ.

    Aliment Pharmacol Ther. 2008 Aug 1;28(3):353-63.PMID: 18638075 [PubMed - indexed for MEDLINE]Related articles

    9.

    Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis.

    Song K, Fendrick AM, Ladabaum U.

    Gastroenterology. 2004 May;126(5):1270-9.PMID: 15131787 [PubMed - indexed for MEDLINE]Related articles

    10.

    Cost-effectiveness analysis of colorectal cancer screening with stool DNA testing in intermediate-incidence countries.

    Wu GH, Wang YM, Yen AM, Wong JM, Lai HC, Warwick J, Chen TH.

    BMC Cancer. 2006 May 24;6:136.PMID: 16723013 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Potential effect of cyclooxygenase-2-specific inhibitors on the prevention of colorectal cancer: a cost-effectiveness analysis.

    Ladabaum U, Scheiman JM, Fendrick AM.

    Am J Med. 2003 May;114(7):546-54.PMID: 12753878 [PubMed - indexed for MEDLINE]Related articles

    12.

    Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force.

    Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz KM.

    Ann Intern Med. 2008 Nov 4;149(9):659-69. Epub 2008 Oct 6.PMID: 18838717 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Aspirin chemoprevention in patients with increased risk for colorectal cancer: a cost-effectiveness analysis.

    DuPont AW, Arguedas MR, Wilcox CM.

    Aliment Pharmacol Ther. 2007 Aug 1;26(3):431-41. Review.PMID: 17635378 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Which colon cancer screening test? A comparison of costs, effectiveness, and compliance.

    Vijan S, Hwang EW, Hofer TP, Hayward RA.

    Am J Med. 2001 Dec 1;111(8):593-601.PMID: 11755501 [PubMed - indexed for MEDLINE]Related articles

    15.

    Cost effectiveness of colorectal cancer screening in the elderly.

    Wagner JL, Herdman RC, Wadhwa S.

    Ann Intern Med. 1991 Nov 15;115(10):807-17.PMID: 1929029 [PubMed - indexed for MEDLINE]Related articles

    16.

    Cost-effectiveness of screening the average-risk population for colorectal cancer.

    Provenzale D.

    Gastrointest Endosc Clin N Am. 2002 Jan;12(1):93-109.PMID: 11916165 [PubMed - indexed for MEDLINE]Related articles

    17.

    Estimates of costs and effects of screening for colorectal cancer in the United States.

    Byers T, Gorsky R.

    Cancer. 1992 Sep 1;70(5 Suppl):1288-95.PMID: 1387342 [PubMed - indexed for MEDLINE]Related articles

    18.

    Initial evaluation of rectal bleeding in young persons: a cost-effectiveness analysis.

    Lewis JD, Brown A, Localio AR, Schwartz JS.

    Ann Intern Med. 2002 Jan 15;136(2):99-110.PMID: 11790061 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Cutting cost and increasing access to colorectal cancer screening: another approach to following the guidelines.

    Fisher JA, Fikry C, Troxel AB.

    Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):108-13. Review.PMID: 16434595 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Cost-effectiveness analysis of fecal occult blood screening for colorectal cancer.

    Lejeune C, Arveux P, Dancourt V, Béjean S, Bonithon-Kopp C, Faivre J.

    Int J Technol Assess Health Care. 2004 Fall;20(4):434-9.PMID: 15609792 [PubMed - indexed for MEDLINE]Related articles